ANS Industries Publishes FY 2025-26 Audited Financial Results
ANS Industries (BSE: ANSINDUS) has announced the publication of its audited financial results for the quarter and year ended March 31, 2026, in compliance with SEBI regulations.
ANS Industries (BSE: ANSINDUS) has announced the publication of its audited financial results for the quarter and year ended March 31, 2026, in compliance with SEBI regulations.
Omkar Pharmachem has published its audited financial results for Q4 and the fiscal year ended March 31, 2026, through official newspaper publications.
ANS Industries has released its audited financial results for the quarter and fiscal year ending March 31, 2026, through a regulatory filing with BSE under SEBI disclosure norms.
ANS Industries has released its audited financial results for Q4 and FY2026, published via newspaper advertisement in compliance with SEBI regulations.
IIFL Finance Limited has informed the NSE about an investor presentation, providing stakeholders with updated corporate information.
IIFL Finance Limited has notified the National Stock Exchange regarding an investor presentation, though the exchange filing contains no detailed financial metrics or commentary.
IIFL Finance Limited has notified the National Stock Exchange about an investor presentation, keeping shareholders informed about company developments.
Samvardhana Motherson International (NSE: MOTHERSON) has announced a schedule of investor meetings to be held in June 2026, spanning four dates with both virtual and physical participation options.
Samvardhana Motherson International has disclosed investor meet dates across four days in June 2026, with both virtual and physical attendance options.
Samvardhana Motherson International has announced a series of investor meet sessions scheduled for June 2026, offering both virtual and physical participation options.
Khadim India (KHADIM) conducted an investor meet on May 26, 2026, with the earnings call transcript released for public reference on BSE.
ITCONS E-Solutions has secured a work order valued at Rs 12,304,256.25 from the Indian Council of Medical Research, according to a recent BSE regulatory filing by the company.
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.